ストックスクリーナーアプリを入手
0.00
100.00%
-11.00
アフターアワーズ：
11.00
11.00
+
前日終値:
$11.00
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$18.95M
収益：
$8.62M
当期純損益:
$-6.15M
株価収益率:
0.00
EPS:
-11.03
ネットキャッシュフロー:
$-5.32M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$11.00
Evoke Pharma Inc Stock (EVOK) Company Profile
EVOK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
0.00 | 18.95M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-06-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 再開されました | FBR & Co. | Buy |
| 2017-03-16 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-01-30 | アップグレード | Laidlaw | Neutral → Buy |
| 2017-01-05 | アップグレード | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 繰り返されました | Rodman & Renshaw | Neutral |
| 2016-07-19 | 繰り返されました | FBR Capital | Outperform |
| 2016-07-19 | ダウングレード | Noble Financial | Buy → Hold |
| 2016-07-18 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 開始されました | Northland Capital | Outperform |
| 2016-03-14 | 繰り返されました | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 再開されました | FBR Capital | Outperform |
| 2014-12-03 | 繰り返されました | MLV & Co | Buy |
| 2014-11-07 | 開始されました | MLV & Co | Buy |
| 2014-04-22 | 開始されました | Laidlaw | Buy |
| 2013-11-19 | 開始されました | Aegis Capital | Buy |
すべてを表示
Evoke Pharma Inc (EVOK) 最新ニュース
Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - MarketsMojo
Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo
Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo
Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - ulpravda.ru
Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - MarketsMojo
What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru
Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - ulpravda.ru
Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru
Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - ulpravda.ru
How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - ulpravda.ru
How Evoke Pharma Inc. stock performs in stagflationTrade Analysis Report & Stepwise Swing Trade Plans - ulpravda.ru
Evoke Pharma, Inc.Common Stock (NQ: EVOK - FinancialContent
How Evoke Pharma Inc. stock performs after earningsSwing Trading Watchlist & Free Strong Return On Assets - ulpravda.ru
Evoke Pharma Leads Pharmaceuticals Sector with 137.07% Annual Return - MarketsMojo
Operating cash flow per share of Evoke Pharma, Inc. – SWB:EV0 - TradingView — Track All Markets
Evoke Pharma Achieves 304.41% Return Amid Strong Market Performance - MarketsMojo
Evoke Pharma Achieves 313.53% Return; InnovAge Holding Up 31.39% - Markets Mojo
Evoke Pharma Achieves 313.53% Return Amid Market Volatility - Markets Mojo
Evoke Pharma Leads with 124.95% Return Among Notable Stock Performers - Markets Mojo
Evoke Pharma Leads Stock Performance with 148.87% Return in Pharmaceuticals Sector - Markets Mojo
Evoke Pharma Leads with 148.87% Return Among High-Performing Stocks - MarketsMojo
Bank Watch: Will Evoke Pharma Inc stock gain from strong economyQuarterly Earnings Report & Smart Allocation Stock Reports - moha.gov.vn
Evoke Pharma Leads Impressive Stock Returns with 126.34% Gain - MarketsMojo
Evoke Pharma Achieves 318.7% Return, Leading Pharmaceutical Stocks Performance - MarketsMojo
Evoke Pharma Leads Six-Month Stock Returns with 316.67% Gain - Markets Mojo
Evoke Pharma Achieves 316.67% Return, Leading Pharmaceutical Sector Performance - MarketsMojo
Evoke Pharma, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Evoke Pharma Leads Stocks with 124.49% Return in Pharmaceuticals Sector - Markets Mojo
Evoke Pharma Leads Six-Month Stock Returns with 298.55% Gain - MarketsMojo
Evoke Pharma Achieves 340% Return, Leading Recent Stock Performers - MarketsMojo
Evoke Pharma Leads Stock Returns with 121.77% Gain Over Past Year - MarketsMojo
Evoke Pharma Leads Stock Performance with 100.36% Return in Past Year - MarketsMojo
Evoke Pharma Leads Six-Month Stock Performance with 303.23% Return - MarketsMojo
Why Evoke Pharma Inc. stock attracts global investorsMarket Trend Summary & Verified Technical Signals - Улправда
Is Evoke Pharma Inc. stock dividend yield sustainable2025 Key Highlights & Community Consensus Trade Alerts - Улправда
Can Evoke Pharma Inc. stock sustain revenue growthAnalyst Downgrade & Low Risk Investment Opportunities - Улправда
Aug Sentiment: Is Evoke Pharma Inc. stock dividend yield sustainable2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Can Evoke Pharma Inc. stock hit analyst price targetsWeekly Trade Recap & Proven Capital Preservation Methods - DonanımHaber
Evoke Pharma Leads Stock Performance with 150% Return in Past Year - Markets Mojo
Evoke Pharma Leads Six-Month Stock Performance with 296.4% Return - Markets Mojo
Will Evoke Pharma Inc. stock benefit from infrastructure spendingJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда
Is Evoke Pharma Inc. stock trading near support levels2025 Trading Volume Trends & Community Driven Trade Alerts - Улправда
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer - BioSpace
Evoke Pharma acquired by QOL Medical, shares to be delisted from Nasdaq - Investing.com Canada
Evoke Pharma (NASDAQ: EVOK) clears shelf registrations following QOL Medical deal - Stock Titan
Evoke Pharma (EVOK) deregisters unsold securities following QOL Medical merger - Stock Titan
Evoke Pharma Inc (EVOK) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
1.55%
大文字化:
|
ボリューム (24 時間):